Ryutaro Ikegami
Overview
Explore the profile of Ryutaro Ikegami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoneyama S, Hoyano M, Ozaki K, Ikegami R, Kubota N, Okubo T, et al.
Heart Vessels
. 2024 Jul;
40(1):8-15.
PMID: 38981910
Continuous intravenous adenosine triphosphate (ATP) administration is the standard method for inducing maximal hyperemia in fractional flow reserve (FFR) measurements. Several cases have demonstrated fluctuations in the ratio of mean...
2.
Akiyama T, Ikegami R, Kubota N, Takano T, Yoneyama S, Okubo T, et al.
Circ J
. 2024 Jun;
88(11):1770-1777.
PMID: 38897974
Background: Because apolipoprotein-A2 (ApoA2), a key component of high-density lipoprotein cholesterol (HDL-C), lacks clear clinical significance, we investigated its impact on cardiovascular events in patients undergoing percutaneous coronary intervention (PCI)....
3.
Ikegami R, Piao Z, Iglesias J, Pilgrim T, Ha K, McCarthy J, et al.
EuroIntervention
. 2024 May;
20(10):e669-e680.
PMID: 38776143
Background: Compared with thin-strut durable-polymer drug-eluting stents (DP-DES), ultrathin-strut biodegradable-polymer sirolimus-eluting stents (BP-SES) improve stent-related clinical outcomes in patients undergoing percutaneous coronary intervention (PCI). Reduced stent strut thickness is hypothesised...
4.
Hoyano M, Ozaki K, Kubota N, Yoneyama S, Okubo T, Ikegami R, et al.
Intern Med
. 2024 Feb;
63(20):2801-2806.
PMID: 38403759
A 37-year-old man with a history of Kawasaki disease presented with total occlusion of the right coronary artery. The patient underwent percutaneous coronary intervention (PCI) with excimer laser coronary angioplasty...
5.
Yoneyama S, Kubota N, Ozaki K, Okubo T, Ikegami R, Hoyano M, et al.
Circ J
. 2023 Sep;
87(11):1705.
PMID: 37704440
No abstract available.
6.
Suda M, Shimizu I, Katsuumi G, Yoshida Y, Hayashi Y, Ikegami R, et al.
Nat Aging
. 2023 Apr;
1(12):1117-1126.
PMID: 37117524
Elimination of senescent cells (senolysis) was recently reported to improve normal and pathological changes associated with aging in mice. However, most senolytic agents inhibit antiapoptotic pathways, raising the possibility of...
7.
Akiyama T, Ozaki K, Takano T, Yoneyama S, Kubota N, Okubo T, et al.
Intern Med
. 2023 Apr;
62(22):3361-3365.
PMID: 37005262
A 57-year-old woman experienced chest pain. A coronary angiogram revealed middle left anterior descending artery stenosis. Despite receiving adequate anti-hyperlipidemia treatment and undergoing percutaneous coronary intervention (PCI), she experienced angina...
8.
Yoneyama S, Ozaki K, Kubota N, Okubo T, Ikegami R, Hoyano M, et al.
Circ J
. 2023 Mar;
87(6):852.
PMID: 36967132
No abstract available.
9.
Kubota N, Ozaki K, Akiyama T, Washiyama Y, Yoneyama S, Okubo T, et al.
Circ Rep
. 2022 Aug;
4(8):363-370.
PMID: 36032388
The correlation between the Japanese version of high bleeding risk (J-HBR) criteria and the Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE-DAPT) score is...
10.
Hayashi Y, Shimizu I, Yoshida Y, Ikegami R, Suda M, Katsuumi G, et al.
iScience
. 2022 Jun;
25(7):104547.
PMID: 35754738
Brown adipose tissue (BAT) has a role in maintaining systemic metabolic health in rodents and humans. Here, we show that metabolic stress induces BAT to produce coagulation factors, which then-together...